ATE279425T1 - Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel - Google Patents

Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel

Info

Publication number
ATE279425T1
ATE279425T1 AT01991315T AT01991315T ATE279425T1 AT E279425 T1 ATE279425 T1 AT E279425T1 AT 01991315 T AT01991315 T AT 01991315T AT 01991315 T AT01991315 T AT 01991315T AT E279425 T1 ATE279425 T1 AT E279425T1
Authority
AT
Austria
Prior art keywords
hypocholesterdenic
azetidinones
drugs
usable
sugar substituted
Prior art date
Application number
AT01991315T
Other languages
English (en)
Inventor
Anima Ghosal
Shmuel Zbaida
Swapan K Chowdhury
Robert M Iannucci
Wenqing Feng
Kevin B Alton
James E Patrick
Harry R Davis
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22973953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE279425(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE279425T1 publication Critical patent/ATE279425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT01991315T 2000-12-20 2001-12-17 Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel ATE279425T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25687500P 2000-12-20 2000-12-20
PCT/US2001/049127 WO2002050090A1 (en) 2000-12-20 2001-12-17 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents

Publications (1)

Publication Number Publication Date
ATE279425T1 true ATE279425T1 (de) 2004-10-15

Family

ID=22973953

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05004699T ATE369334T1 (de) 2000-12-20 2001-12-17 Hydroxysubstituierte 2-azetidinone verwendbar als hypocholesterolemische arzneimittel
AT01991315T ATE279425T1 (de) 2000-12-20 2001-12-17 Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05004699T ATE369334T1 (de) 2000-12-20 2001-12-17 Hydroxysubstituierte 2-azetidinone verwendbar als hypocholesterolemische arzneimittel

Country Status (35)

Country Link
US (1) US20020137690A1 (de)
EP (1) EP1347987B1 (de)
JP (2) JP4351842B2 (de)
KR (1) KR100883461B1 (de)
CN (1) CN100475829C (de)
AR (1) AR035611A1 (de)
AT (2) ATE369334T1 (de)
AU (2) AU2002231049B2 (de)
BR (1) BR0116212A (de)
CA (1) CA2432798C (de)
CY (1) CY1106912T1 (de)
CZ (1) CZ302193B6 (de)
DE (2) DE60129863T2 (de)
DK (2) DK1347987T3 (de)
EC (1) ECSP034659A (de)
ES (2) ES2287826T3 (de)
GE (1) GEP20053548B (de)
HK (2) HK1056735A1 (de)
HU (1) HUP0302269A3 (de)
IL (1) IL155771A0 (de)
MA (1) MA26975A1 (de)
MX (1) MXPA03005671A (de)
MY (1) MY129148A (de)
NO (2) NO326981B1 (de)
NZ (1) NZ525722A (de)
PE (1) PE20020718A1 (de)
PL (1) PL208242B1 (de)
PT (2) PT1593670E (de)
RU (1) RU2297422C2 (de)
SI (2) SI1593670T1 (de)
SK (1) SK286703B6 (de)
TR (1) TR200402758T4 (de)
TW (1) TWI316942B (de)
WO (1) WO2002050090A1 (de)
ZA (1) ZA200303694B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157552A0 (en) 2001-03-28 2004-03-28 Schering Corp Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
JP2005015434A (ja) 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (de) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Neue hypocholesterolemische Verbindungen
EP1918000A2 (de) 2003-11-05 2008-05-07 Schering Corporation Verbindungen aus lipidverändernden Wirkstoffen und substituierten Azetidinonen und Behandlungen für Gefäßzustände
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
US7871998B2 (en) 2003-12-23 2011-01-18 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
AU2004308332B2 (en) 2003-12-23 2008-04-10 Merck Sharp & Dohme Corp. Anti-hypercholesterolemic compounds
EP1807070A1 (de) * 2004-09-29 2007-07-18 Schering Corporation Kombinationen aus substituierten azetidinonen und cb1-antagonisten
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
SA06270191B1 (ar) * 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
CA2644905A1 (en) * 2006-03-06 2007-09-13 Teva Pharmaceutical Industries Ltd. Ezetimibe compositions
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
AR065913A1 (es) * 2007-04-02 2009-07-08 Theracos Inc Derivados de glicosido bencilico, composicion y combinacion farmaceutica y uso
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
EP2379547A1 (de) 2008-12-16 2011-10-26 Schering Corporation Pyridopyrimidinderivate und verfahren zu deren anwendung
KR20110120320A (ko) * 2009-02-11 2011-11-03 다우 아그로사이언시즈 엘엘씨 살충 조성물
EP2403848A1 (de) 2009-03-06 2012-01-11 Lipideon Biotechnology AG Pharmazeutische hypocholesterinemische zusammensetzungen
CA2757722C (en) 2009-04-01 2018-05-22 Matrix Laboratories Ltd. Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
KR101102749B1 (ko) * 2009-11-30 2012-01-05 최길용 곱셈 학습기
KR20150079373A (ko) 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
CN105055404B (zh) * 2015-08-19 2017-07-18 四川大学 Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) * 1994-03-25 1997-05-06 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
DK0877750T3 (da) * 1995-10-31 2002-07-15 Schering Corp Som hypocholesterolemiske midler velegnede, sukkersubstituerede 2-azetidinoner
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AUPQ342599A0 (en) * 1999-10-14 1999-11-04 University Of Melbourne, The Conjugates and uses thereof

Also Published As

Publication number Publication date
EP1347987B1 (de) 2004-10-13
CA2432798C (en) 2007-02-27
HK1056735A1 (en) 2004-02-27
MY129148A (en) 2007-03-30
DK1593670T3 (da) 2007-11-05
SI1593670T1 (sl) 2007-12-31
NZ525722A (en) 2004-11-26
CN100475829C (zh) 2009-04-08
EP1347987A1 (de) 2003-10-01
RU2003122520A (ru) 2005-02-27
HUP0302269A3 (en) 2009-08-28
CY1106912T1 (el) 2012-09-26
WO2002050090A1 (en) 2002-06-27
US20020137690A1 (en) 2002-09-26
ZA200303694B (en) 2004-08-13
GEP20053548B (en) 2005-06-27
CA2432798A1 (en) 2002-06-27
DE60129863T2 (de) 2008-04-30
TWI316942B (en) 2009-11-11
MA26975A1 (fr) 2004-12-20
KR20030063414A (ko) 2003-07-28
SK286703B6 (sk) 2009-03-05
NO20032806L (no) 2003-08-19
NO20083737L (no) 2003-08-19
JP2009132745A (ja) 2009-06-18
MXPA03005671A (es) 2003-10-06
ATE369334T1 (de) 2007-08-15
PT1347987E (pt) 2005-01-31
WO2002050090A8 (en) 2004-04-15
NO326981B1 (no) 2009-03-30
SK7702003A3 (en) 2003-10-07
AU2002231049B2 (en) 2006-07-20
KR100883461B1 (ko) 2009-02-16
SI1347987T1 (en) 2005-02-28
JP2004516299A (ja) 2004-06-03
AU3104902A (en) 2002-07-01
DE60106489T2 (de) 2005-10-13
ES2230385T3 (es) 2005-05-01
DE60106489D1 (de) 2004-11-18
DK1347987T3 (da) 2005-01-31
PL208242B1 (pl) 2011-04-29
ECSP034659A (es) 2003-07-25
AR035611A1 (es) 2004-06-16
NO20032806D0 (no) 2003-06-19
IL155771A0 (en) 2003-12-23
DE60129863D1 (de) 2007-09-20
CZ302193B6 (cs) 2010-12-08
RU2297422C2 (ru) 2007-04-20
HK1084945A1 (en) 2006-08-11
TR200402758T4 (tr) 2004-11-22
ES2287826T3 (es) 2007-12-16
CN1483039A (zh) 2004-03-17
HUP0302269A2 (hu) 2003-10-28
PE20020718A1 (es) 2002-08-09
PT1593670E (pt) 2007-11-08
BR0116212A (pt) 2003-12-30
JP4351842B2 (ja) 2009-10-28
CZ20031674A3 (cs) 2003-10-15
PL363237A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
ATE279425T1 (de) Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel
ATE219495T1 (de) Zuckersubstituierte 2-azetidinone, verwendbar als hypocholesterdenische arzneimittel
NO20032236D0 (no) Laktamforbindelse
DE50204037D1 (de) Substituierte 1-oxa-2,8-diaza-spiro[4,5]dec-2-en-derivate als arzneimittel gegen schmerz
DE60037455D1 (de) Kinaseinhibitoren als arzneimittel
ATE339417T1 (de) Biphenyl - sulfonamide als duale angiotensin - endothelin - rezeptor - antagonisten
FI20011478A (fi) Farmaseuttinen koostumus
DK1575618T3 (da) Dispergerbare farmaceutiske kombinationer
BR0212703B1 (pt) fibra bicomponente.
DE502004009059D1 (de) 11-((4R,6R)-4,5,6-Trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-Undekansäure
DK1395957T3 (da) Dualt vejafgiftssystem
MXPA03001425A (es) Compuestos farmaceuticos.
NO20035315D0 (no) Farmasöytiske kombinasjoner
NO20022606L (no) Farmasöytiske kombinasjoner
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
AP2004003066A0 (en) Pharmaceutical compositions based on azetidine derivatives.
NO20032215L (no) Laktamforbindelse
DE50206096D1 (de) Substituierte benzoäbüazepin-2-on-verbindungen als schmerzmittel
AU2001291690A1 (en) Drugs for sex dysfunctions
ATE405569T1 (de) Pentacyclische taxan-verbindungen
ES1050610Y (es) Tornillo de seguridad.
DE50202621D1 (de) Zentrifuge
DE10291905D2 (de) Pharmazeutische Zusammensetzung
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20025598D0 (no) Svingdör

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1347987

Country of ref document: EP